Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer detection and the community pharmacist.

B L Lum, D S McWaters, M A Mergener

    American Pharmacy
    |July 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?

    Clinical pharmacology and therapeutics·2016
    Same author

    Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometry.

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2010
    Same author

    A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance.

    Annals of oncology : official journal of the European Society for Medical Oncology·2005
    Same author

    Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.

    Leukemia·2002
    Same author

    Long-term results of irradiation for patients with progressive Graves' ophthalmopathy.

    International journal of radiation oncology, biology, physics·2001
    Same journal

    Genetically engineered vaccines.

    American pharmacy·1995
    Same journal

    GAO report on need for a third class: 'prove it'.

    American pharmacy·1995
    Same journal

    Treatment of community-acquired urinary tract infections.

    American pharmacy·1995
    Same journal

    Liability and the changing role of pharmacists.

    American pharmacy·1995
    Same journal

    Dispensing errors and counseling in community practice.

    American pharmacy·1995
    Same journal

    Avoiding liability problems. American Pharmaceutical Association.

    American pharmacy·1995
    See all related articles

    Community pharmacists frequently advise patients on cancer symptoms, yet often lack confidence in recognizing less common signs. Enhanced education is crucial for their role in early cancer detection and prevention.

    Area of Science:

    • Oncology
    • Pharmacy Practice
    • Public Health

    Background:

    • Community pharmacists are accessible healthcare professionals.
    • Patients often seek advice regarding potential cancer signs and symptoms from pharmacists.
    • Pharmacists' current knowledge and confidence in recognizing diverse cancer symptomatology require evaluation.

    Purpose of the Study:

    • To assess community pharmacists' perceptions of their ability to recognize cancer signs and symptoms.
    • To determine pharmacists' preferred methods for continuing education on cancer symptomatology.
    • To evaluate the potential role of pharmacists in early cancer detection.

    Main Methods:

    • A questionnaire was distributed to 5,539 community pharmacists.
    • 1,187 questionnaires were returned and analyzed.

    Related Experiment Videos

  • Data collected included patient interaction frequency, self-perceived recognition abilities, and educational preferences.

    • Main Results:

    • 70% of pharmacists reported monthly patient inquiries about cancer symptoms.
    • Nearly half noted patients attempting self-treatment for these symptoms.
    • Pharmacists felt confident recognizing common cancers (skin, breast, colorectal) but not others.
    • All pharmacists deemed cancer symptomatology education important, but lacked consensus on delivery format.

    Conclusions:

    • Community pharmacists are well-positioned to contribute to early cancer detection and prevention.
    • Significant patient interaction regarding cancer symptoms highlights this potential.
    • Further pharmacist education in cancer detection is warranted to improve patient outcomes.